Bhageria Industries Limited has submitted to the Exchange, the Unaudited financial results (Standalone & Consolidated) for the quarter ended June 30, 2025.
BHAGERIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bhageria Industries reported strong Q1 FY26 results, with standalone revenue from operations rising about 40% year-on-year to Rs. 15,800.38 lakhs (vs Rs. 11,252.50 lakhs in Q1 FY25). Standalone profit after tax nearly doubled to Rs. 1,199.04 lakhs (vs Rs. 608.84 lakhs), translating to basic EPS of Rs. 2.75 (vs Rs. 1.40). Profit before tax jumped to Rs. 1,653.03 lakhs from Rs. 831.35 lakhs, indicating margin expansion driven mainly by the Chemical segment, which contributed Rs. 14,677.73 lakhs of revenue and Rs. 1,507.94 lakhs of segment profit. The Pharma segment continued to post a loss of Rs. 151.83 lakhs, while Solar Power remained profitable. Consolidated PAT rose to Rs. 1,088.26 lakhs (vs Rs. 581.23 lakhs). The board also approved closure of its Bahrain wholly-owned subsidiary (Bhageria Industries Holding Company W.L.L.) by December 31, 2025 to streamline its international structure, as the local Bahrain branch is operationally sufficient. Statutory auditors (Sarda & Pareek LLP) issued an unmodified limited review report.
Strong double-digit revenue growth, near-doubling of profits, and margin expansion are positive for shareholders, suggesting improved operating leverage especially in the Chemical segment. The Bahrain subsidiary closure has negligible financial impact (nil revenue, net worth of only 567 BHD), so it is a housekeeping move rather than a material event.